Astellas Venture Management

Astellas Venture Management is the wholly-owned venture capital organization within Astellas, dedicated to supporting pre-clinical, cutting-edge science that can bring VALUE to patients. For over 20 years, AVM has provided equity investments to private, early-stage companies developing therapeutic programs and platform technologies, helping them to advance their innovations faster. AVM is a strategic investor, making investments in science that will enhance the current Astellas R&D pipeline or that could catalyze new directions in discovery research. We will make an investment in a privately owned early-stage biotechnology company focused on therapeutics programs and platform technologies for drug discovery and development. Program stage should be in preclinical to be considered an equity investment. Our areas of interest are innovative therapeutic approach which is close to the R&D strategy of Astellas Pharma and unprecedented treatment, but that will become realized in the near future. We prioritize companies with programs and technologies to fulfill unmet medical needs that have been lacking.